Нажмите на эту строку чтобы перейти к Новостям сайта "Русский врач"

Перейти
на сайт
журнала
"Врач"
Перейти на сайт журнала "Медицинская сестра"
Перейти на сайт журнала "Фармация"
Перейти на сайт журнала "Молекулярная медицина"
Перейти на сайт журнала "Вопросы биологической, медицинской и фармацевтической химии"
Журнал включен в российские и международные библиотечные и реферативные базы данных

ВАК (Россия)
РИНЦ (Россия)
Эко-Вектор (Россия)

SUCCINATE-RECEPTOR SYSTEM OF BONE AND CARTILAGE TISSUE IN PATIENTS WITH METABOLIC PHENOTYPE OF OSTEOARTHRITIS

DOI: https://doi.org/10.29296/25877313-2024-04-06
Issue: 
4
Year: 
2024

D.R. Shodiev
Post-graduate Student,
Ryazan State Medical University named after acad. I.P. Pavlov (Ryazan, Russia)
E-mail: shodiev.dima@yandex.ru; SPIN 3556-4398; ORCID 0000-0002-4530-2964
V.I. Zvyagina
Dr.Sc. (Med.), Professor of Department of Biochemistry,
Ryazan State Medical University named after acad. I.P. Pavlov (Ryazan, Russia)
E-mail: vizvyagina@yandex.ru; SPIN: 7553-8641; ORCID: 0000-0003-2800-5789; Scopus Author ID: 57189726173
M.N. Ryabova
Ph.D. (Med.), Associate Professor of Department of General Surgery, Traumatology and Orthopedics,
Ryazan State Medical University named after acad. I.P. Pavlov (Ryazan, Russia)
E-mail: rmn62doc@yandex.ru; SPIN: 2077-3173; ORCID: 0000-0002-1707-2567
Y.A. Marsyanova
Assistant, Department of Biochemistry,
Ryazan State Medical University named after acad. I.P. Pavlov (Ryazan, Russia)
E-mail: yuliyamarsyanova@yahoo.com; SPIN: 4075-3169; ORCID 0000-0003-4948-4504

Introduction. Currently, osteoarthritis (OA) has been identified as a polyetiological disease, where several phenotypes have been identified based on the leading frequency. Obviously, each clinical phenotype corresponds only to its fundamental changes on the part of various organs and systems. Un-til recently, special attention was paid to the study of metabolic processes in osteoarthritis (OA) and was paid to the state of the cartilage, but more and more interest was focused on the biochemistry of the subchondral bone, its microarchitectonics and signal function. Aid. To study the features of the manifestation of the succinate-receptor system of bone and cartilage tissue in patients with the metabolic phenotype of osteoarthritis. Material and methods. 42 patients took part in the study and were divided into 2 groups: 1 group – patients without articular disease, normal body mass index; 2 group – patients with metabolic phenotype of OA. The subjects were collected complaints, anamnesis, as well as general clinical and orthopedic examination. The levels of succinate, succinate receptor (SUCNR1) and succinate dehydrogenase (SDH) are measured in bone and cartilage tissue homogenates. Results. In the 2 group, an increase in SUCNR1 expression was detected in all studied areas of the joint in comparison with the 1 group. In the 2 group, the differences were tissue-specific in the distribution of SUCNR1 with a predominant increase in the amount of the receptor in the subchondral bone compared to the loaded (p=0.031) and non-loaded zone of cartilage (p=0.001). In the 1 group, the studied areas of cartilage and bone did not dif-fer in the amount of SUCNR1 from each other. In the group of patients with the metabolic phenotype of OA, an increase in mitochondrial succinate was found both in the subchondral bone tissue and in different zones of cartilage compared to the 1 group. The final indicators of SDH activity in the mito-chondria of the studied joint zones that we obtained turned out to be low in both groups, however, relatively high enzyme activity was observed in the subchondral zone of the bone of the group of metabolic phenotype of OA. Conclusion. In patients with the metabolic phenotype of OA, high expression of SUCNR1 in joint tissues is observed, which is tissue-specific with a predominant increase in the amount of SUCNR1 in the subchondral bone. We found higher levels of succinate in the subchondral bone and cartilaginous areas of joints in patients with the metabolic phenotype of OA and suggest that the succinate-SUCNR1 interaction in affected joints in OA is adaptive in nature.

Keywords: 
obesity
osteoarthritis
metabolic phenotype
succinate
succinate receptor 1
SUCNR1.

References: 
  1. Каминский А.В., Матвеева Е.Л., Гасанова А.Г. и др. Анализ биохимических показателей сыворотки крови у больных с ре-визионным эндопротезированием тазобедренного сустава и нарушением углеводного обмена. Наука молодых (Eruditio Juvenium). 2023;11(1):5–14. https://doi.org/10.23888/HMJ20231115-14. [Kaminskiy A.V., Matveyeva E.L., Gasanova A.G. et al. Analysis of Biochemical Parameters of Blood Serum in Patients with Revision Hip Arthroplasty and Disorder of Carbohydrate Metabolism. Science of the young (Eruditio Juvenium). 2023;11(1):5–14. https://doi.org/10.23888/HMJ20231115-14. (In Russ.)]
  2. van Diepen J.A., Robben J.H., Hooiveld G.J. et al. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes. Diabetologia. 2017;60(7):1304–1313. DOI: 10.1007/s00125-017-4261-z.
  3. Бельских Э.С., Урясьев О.М., Звягина В.И., Фалетрова С.В. Сукцинат и сукцинатдегидрогеназа моно-ядерных лейкоцитов крови как маркеры адаптации митохондрий к гипоксии у боль-ных при обострении хронической обструктивной болезни лег-ких. Российский медико-биологический вестник им. академика И.П. Павлова. 2020;28(1):13–20. DOI: 10.23888/PAVLOVJ202028113-20. [Belskikh E.S., Uryasiev O.M., Zvyagina V.I., Faletrova S.V. Succinate and succinate dehydrogenase of mononuclear blood leukocytes as markers of adaptation of mitochondria to hypoxia in patients with exacerbation of chronic obstructive pulmonary disease. I.P. Pavlov Russian Medical Biological Herald. 2020;28(1)13–20. DOI: 10.23888/PAVLOVJ202028113-20. (In Russ.)].
  4. Tannahill G.M., Curtis A.M., Adamik J. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 2013;496(7444):238–242. DOI: 10.1038/nature11986.
  5. Li Y., Zheng J.Y., Liu J.Q. et al. Succinate/NLRP3 Inflammasome Induces Synovial Fibroblast Activation: Therapeutical Effects of Clematichinenoside AR on Arthritis. Front Immunol. 2016;7:532. DOI: 10.3389/fimmu.2016.00532.
  6. Li Y., Liu Y., Wang C. et al. Succinate induces synovial angiogenesis in rheumatoid arthritis through metabolic remodeling and HIF-1α/VEGF axis. Free Radic Biol Med. 2018;126:1–14. DOI: 10.1016/j.freeradbiomed.2018.07.009.
  7. Su W., Liu G., Liu X. et al. Angiogenesis stimulated by elevated PDGF-BB in subchondral bone contributes to osteoarthritis development. JCI Insight. 2020;5(8):e135446. DOI: 10.1172/jci.insight.135446.
  8. Deen P.M., Robben J.H. Succinate receptors in the kidney. J Am Soc Nephrol. 2011;22(8):1416–1422. DOI: 10.1681/ASN.2010050481.
  9. Macias-Ceja D.C., Ortiz-Masiá D., Salvador P. et al. Succinate receptor mediates intestinal inflammation and fibrosis. Mucosal Immunol. 2019;12(1):178–187. DOI: 10.1038/s41385-018-0087-3.
  10. Lukyanova L.D., Kirova Y.I., Germanova E.L. Specific Fea-tures of Immediate Expression of Succinate-Dependent Re-ceptor GPR91 in Tissues during Hypoxia. Bull Exp Biol Med. 2016;160(6):742–747. DOI: 10.1007/s10517-016-3299-0.
  11. Keiran N., Ceperuelo-Mallafré V., Calvo E. et al. SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity. Nat Immunol. 2019;20(5):581–592. DOI: 10.1038/s41590-019-0372-7.
  12. Huang Z., He Z., Kong Y.et al. Insight into osteoarthritis through integrative analysis of metabolomics and transcriptomics. Clin Chim Acta. 2020;510:323–329. DOI: 10.1016/j.cca.2020.07.010.
  13. Gavriilidis C., Miwa S., von Zglinicki T. et al. Mitochondrial dysfunction in osteoarthritis is associated with down-regulation of superoxide dismutase 2. Arthritis Rheum. 2013;65(2):378–387. DOI: 10.1002/art.37782.
  14. Rushton M.D., Reynard L.N., Barter M.J. et al. Characterization of the cartilage DNA methylome in knee and hip osteoarthritis. Arthritis Rheumatol. 2014;66(9):2450–2460. DOi: 10.1002/art.38713.
  15. Bianco D., Todorov A., Čengić T. et al. Alterations of Subchondral Bone Progenitor Cells in Human Knee and Hip Osteoarthritis Lead to a Bone Sclerosis Phenotype. Int J Mol Sci. 2018;19(2):475. DOI: 10.3390/ijms19020475.
  16. Мартиросов Э.Г., Николаев Д.В., Руднев С.Г. Технологии и методы определения состава тела человека. М.: Наука, 2006; 248 с. [Martirosov E.G., Nikolaev D.V., Rudnev S.G. Technologies and methods for determining the composition of the human body. M.: Nauka, 2006: 248 p. (In Russ)].
  17. Gallagher D., Heymsfield S.B., Heo M., et al. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72(3):694–701. DOI: 10.1093/ajcn/72.3.694.
  18. Zhang W., Doherty M., Peat G. et al. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis. 2010 ;69(3):483–489. DOI: 10.1136/ard.2009.113100.
  19. Верткин А.Л., Толстов С.Н. и др. Консенсус экспертов по междисциплинарному подходу к ведению, диагностике и лече-нию больных с метаболическим синдромом. Кардиоваскуляр-ная терапия и профилактика. 2013;12(6):41–82. [Vertkin A.L., Tolstov S.N. I dr.Experts’ consensus on the interdisciplinary approach towards the managmeht? Diag-nostics, and treatment of patients with metabolic syndrome. Cardiovascular Therapy and Prevention. 2013;12(6):41–82. (In Russ.)].
  20. Методы биохимических исследований (липидный и энергетиче-ский обмен): учебное пособие / под ред. М.И. Прохоровой. Л.: Издательство 231 Ленинградского университета, 1982,327 с. [Methods of biochemical research (lipid and energy metabolism): textbook / edited by M.I. Pro-khorova. L.: Publishing House 231 of Leningrad University, 1982. 327 p. (In Russ)]
  21. Fernández-Veledo S., Ceperuelo-Mallafré V., Vendrell J. Rethinking succinate: an unexpected hormone-like metabolite in energy homeostasis. Trends Endocrinol Metab. 2021;32(9):680–692. DOI: 10.1016/j.tem.2021.06.003.
  22. Guo Y., Xu F., Thomas S.C. et al. Targeting the succinate receptor effectively inhibits periodontitis. Cell Rep. 2022;40(12):111389. DOI: 10.1016/j.celrep.2022.111389.
  23. Littlewood-Evans A., Sarret S., Apfel V. et al. GPR91 senses extra-cellular succinate released from inflammatory macro-phages and ex-acerbates rheumatoid arthritis. J Exp Med. 2016 Aug 22;213(9):1655–1662. DOI: 10.1084/jem.20160061.
  24. Chouchani E.T., Pell V.R., Gaude E. et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515(7527):431–435. DOI: 10.1038/nature13909.
  25. Liu H., Li Z., Cao Y. et al. Effect of chondrocyte mito-chondrial dysfunction on cartilage degeneration: A possible pathway for oste-oarthritis pathology at the subcellular level. Mol Med Rep. 2019;20(4):3308–3316. DOI: 10.3892/mmr.2019.10559.
  26. Maneiro E., Martín M.A., de Andres M.C., et al. Mito-chondrial respiratory activity is altered in osteoarthritic human articular chon-drocytes. Arthritis Rheum. 2003;48(3):700–708. DOI: 10.1002/art.10837.
  27. Trounce I, Byrne E, Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet. 1989 Mar 25;1(8639):637–639. DOI: 10.1016/s0140-6736(89)92143-0.
  28. Dröse S., Brandt U. Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Adv Exp Med Biol. 2012;748:145–169. DOI: 10.1007/978-1-4614-3573-0_6.